CIK 0001275187
- Accelerated filer
ANGIODYNAMICS INC
Sign in to watch- Ticker
- ANGO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- May 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113146460
- Phone
- +1 518-798-1215
- Business address
- 14 PLAZA DRIVE, LATHAM, NY, 12110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $310,688
- in 1 filing
Net −$310,688. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-21 | GOLD JEFFREY Director | Option exercise · Non-Qualified Stock Option (right to buy) | −7,000 | 0 | ||
| 2018-05-23 | Campbell Chad Thomas SVP/GM, Vascular Access | Shares withheld for taxes | −827 | $20.37 | $17K | 14,497 |
| 2018-04-24 | Trowbridge Stephen A SVP and General Counsel | Shares withheld for taxes | −1,280 | $19.76 | $25K | 33,172 |
| 2018-01-31 | Simpson Robert Arthur SVP/GM, Global Vascular | Shares withheld for taxes | −1,056 | $17.41 | $18K | 12,683 |
| 2017-11-21 | DONNELLY HOWARD W Director | Option exercise | +14,000 | $13.53 | $189K | 69,576 |
| 2017-11-21 | DONNELLY HOWARD W Director | Shares withheld for taxes | −10,873 | $17.42 | $189K | 58,703 |
| 2017-11-21 | DONNELLY HOWARD W Director | Option exercise · Non-Qualified Stock Option (right to buy) | −14,000 | 0 | ||
| 2017-11-15 | Richard Stark SVP, GM - Oncology | Option exercise | +10,000 | $10.63 | $106K | 30,754 |
| 2017-11-15 | Richard Stark SVP, GM - Oncology | Option exercise | +17,409 | $11.92 | $208K | 48,163 |
| 2017-11-15 | Richard Stark SVP, GM - Oncology | Sale | −27,409 | $16.29 | $446K | 20,754 |
| 2017-11-15 | Richard Stark SVP, GM - Oncology | Option exercise · Non-Qualified Stock Option (right to buy) | −10,000 | 0 | ||
| 2017-11-15 | Richard Stark SVP, GM - Oncology | Option exercise · Non-Qualified Stock Option (right to buy) | −17,409 | 0 | ||
| 2017-09-12 | Gould Kevin J Director | Option exercise | +25,000 | $14.31 | $358K | 65,064 |
| 2017-09-12 | Gould Kevin J Director | Shares withheld for taxes | −19,776 | $18.09 | $358K | 45,288 |
| 2017-09-12 | Gould Kevin J Director | Option exercise | +14,000 | $13.53 | $189K | 59,288 |
| 2017-09-12 | Gould Kevin J Director | Shares withheld for taxes | −10,471 | $18.09 | $189K | 48,817 |
| 2017-09-12 | Gould Kevin J Director | Option exercise · Non-Qualified Stock Option (right to buy) | −25,000 | 0 | ||
| 2017-09-12 | Gould Kevin J Director | Option exercise · Non-Qualified Stock Option (right to buy) | −14,000 | 0 | ||
| 2017-08-06 | Trowbridge Stephen A SVP and General Counsel | Shares withheld for taxes | −495 | $16.56 | $8K | 34,452 |
| 2017-08-06 | Richard Stark SVP, GM - Oncology | Shares withheld for taxes | −502 | $16.56 | $8K | 20,754 |
Page 31 of 41 · 813 trades